What we have to know about corticosteroids use during Sars-Cov-2 infection
ConclusionPhysicians involved in the management of patients affected by COVID-19 should be aware of the need of an appropriate GC dose tapering, and of potential interaction of GCs with antiviral therapy and drugs used to treat associated co-morbidities.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Addison's Disease | Adrenal Insufficiency | Antiviral Therapy | Corticosteroid Therapy | COVID-19 | Endocrinology | Outbreaks | Respiratory Medicine | SARS